Lung Cancer Genomic Testing Market Size, Share & Trends Analysis Report By Type (Products, Services), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Fluorescence in Situ Hybridization), By Sample Type (Tissue biopsy, Liquid biopsy), By Panel Type (Multi-Gene panels, Single-Gene panels), By End-User (Research organizations, Hospitals/Clinics, Diagnostic Laboratories) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032
The global cancer genetic testing market size was valued at USD 6.0 billion in 2023 and is projected to reach USD 16.1 billion by 2032, registering a CAGR of 11.6% during the forecast period (2024-2032). The rising incidence of breast and lung cancer
You will receive a link to download the sample pages on your email immediately after filling out a form
A sample report will help you understand the structure of our full report
The sample shared will be for our off-the-shelf market report
The off-the-shelf report is curated considering a broader audience for this market, we have insights extending well beyond the scope of this report. Please reach out to discuss
Should the sample pages not contain the specific information you seek, we extend the option to request additional details, which our dedicated team will incorporate.
The sample is free of cost, while the full report is available for a fee.